Showing results (131-140 of 221) with videos related to

Sort By:
Pageof 23
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|August 10, 2019
Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor 1 Predicts the Changes of Rheumatoid Factor Titers in Rheumatoid ArthritisAkinori Okahata, Hiromu Ito, Moritoshi Furu, et al.
Frontiers in Immunology|April 20, 2026
Long-term outcomes remain unchanged despite reduced glucocorticoid exposure in ANCA-associated vasculitis: the multicentre REVEAL cohort studyMayu Shiomi, Ryu Watanabe, Muneyuki Hatta, et al.
RMD Open|January 30, 2026
Do high rheumatoid factor levels impact response to certolizumab pegol in patients with inadequately controlled rheumatoid arthritis? A post hoc analysis of the phase IIIb REALISTIC trialJosef S Smolen, Ted R Mikuls, James Galloway, et al.
Rheumatology (Oxford, England)|September 2, 2024
Impact of high rheumatoid factor levels on treatment outcomes with certolizumab pegol and adalimumab in patients with rheumatoid arthritisJosef S Smolen, Peter C Taylor, Yoshiya Tanaka, et al.
Rheumatology (Oxford, England)|April 12, 2017
Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodiesShuichiro Nakabo, Motomu Hashimoto, Shinji Ito, et al.
Scientific Reports|March 4, 2021
Habitual fish intake negatively correlates with prevalence of frailty among patients with rheumatoid arthritisHiroto Minamino, Masao Katsushima, Mie Torii, et al.
Clinical Rheumatology|December 14, 2022
Enteric Toll-like receptor 7 stimulation causes acute exacerbation in lupus-susceptible miceYudai Takase, Mirei Shirakashi, Yuri Nishida, et al.
Rheumatology International|July 31, 2020
Comparison of the efficacy and safety of biologic agents between elderly-onset and young-onset RA patients: the ANSWER cohort studySadao Jinno, Akira Onishi, Maureen Dubreuil, et al.
Clinical Rheumatology|March 13, 2020
Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort studyKosuke Ebina, Toru Hirano, Yuichi Maeda, et al.
Arthritis Research & Therapy|June 17, 2020
Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort studyKosuke Ebina, Toru Hirano, Yuichi Maeda, et al.
Pageof 23